About Vats Biotech
Vats Biotech is a company founded in 2015. The company has 30 employees as of April 01, 2024. Vats Biotech offers products and services including Generic Drugs and Vaccines.
- Employees 30 as on 01 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Social
Locked
- Legal Name Vats Biotech Private Limited
- Jurisdiction Jamshedpur, Jharkhand, India
-
Annual Revenue
$1.69 M (USD)155.07as on Mar 31, 2023
-
Net Profit
$9.27 K (USD)43.26as on Mar 31, 2023
-
EBITDA
$15.73 K (USD)32.55as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
30
as on Apr 01, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vats Biotech
Vats Biotech offers a comprehensive portfolio of products and services, including Generic Drugs and Vaccines.
Generic drugs and vaccines are developed and marketed to provide affordable healthcare solutions
Vaccines are supplied to meet global demands, with emphasis on quality and affordability in production
Funding Insights of Vats Biotech
Detailed funding history for Vats Biotech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vats Biotech
Investment portfolio details for Vats Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vats Biotech
Detailed financials for Vats Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vats Biotech Comparisons
Peer comparison for Vats Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vats Biotech
Detailed competitors of Vats Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vats Biotech
Complete news archive for Vats Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vats Biotech
Vats Biotech was founded in 2015.
As of Apr 01, 2024, the latest employee count at Vats Biotech is 30.
Annual revenue of Vats Biotech is $1.69M as on Mar 31, 2023.
Vats Biotech Private Limited is engaged in the development and marketing of affordable healthcare products, particularly generic drugs and vaccines. India is noted for supplying over 50 of global vaccine demand and ranking third in pharmaceutical production by volume. The company is positioned to grow through strategic market penetration, supported by a dedicated team that prioritizes quality and affordability. The domestic pharmaceutical market is expected to expand from US 42 billion in 2021 to US 120-130 billion by 2030, with exports contributing significantly. Efforts are directed towards meeting rising global needs while maintaining high standards.
Vats Biotech offers Generic Drugs and Vaccines.